East Timor Technology Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on East Timor Technology Press.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on October 25, 2025

October 25, 2025

OVIOS Unveils the 114-Inch Cloud Sectional Sofa: A Blend of Luxury, Comfort, and Everyday Versatility

GlobeNewswire

October 25, 2025

From India to the USA: HDFC ERGO’s Guide to Why Travel Insurance is Essential

GlobeNewswire

October 25, 2025

Cyber Heater Unveiled: How the Smart Electric Cyber Heater Is Revolutionizing Home Warmth & Winter Comfort

GlobeNewswire

October 25, 2025

No KYC Casinos 2025: Rakebit Rated as the Leading No Verification Online Casino

GlobeNewswire

October 25, 2025

New Online Casinos Australia 2025: RubyReels Shines as a Premier Gaming Destination

GlobeNewswire

October 25, 2025

DeLeion Capital Highlights BNB Opportunity amid Regulatory Shift and Ecosystem Renewal

GlobeNewswire

October 25, 2025

Avacta presents first preclinical data from dual payload pre|CISION® medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets

GlobeNewswire

October 25, 2025

Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025

GlobeNewswire

October 25, 2025

Quell Therapeutics to Unveil Promising Data for QEL-005, a Novel CAR-Treg Cell Therapy for Complex Autoimmune Diseases, at ACR Convergence 2025

GlobeNewswire

October 25, 2025

Kyverna Therapeutics Highlights Potential of KYV-101 in Rheumatoid Arthritis with Phase 1 Data from Investigator-Initiated Trial Presented at ACR Convergence 2025

GlobeNewswire

October 25, 2025

Phathom Pharmaceuticals Announces Publication of Data from Phase 3 pHalcon-NERD-301 Study Showing VOQUEZNA® (vonoprazan) Improved Nocturnal GERD Symptoms in Patients with Non-Erosive Reflux Disease

GlobeNewswire

October 25, 2025

New Crypto Mutuum Finance (MUTM) Nears V1 Launch After Raising Over $17.8M

GlobeNewswire

October 25, 2025

ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium

GlobeNewswire